The report "Fertility
Testing Devices Market Product (Ovulation Prediction Kit &
Fertility Monitor (Urine-based, Saliva-based, & Basal Body Temperature)),
Mode of Purchase (Prescription & OTC), and Region - Global Forecast to
2020"The global fertility testing devices market was
estimated at USD 151.0 Million in 2015; it is poised to grow at a CAGR of 7.5%
during the forecast period to reach USD 216.8 Million by 2020.
Browse 47 market data
Tables and 35 Figures spread through 122 Pages and in-depth TOC on "Fertility
Testing Devices Market “
http://www.marketsandmarkets.com/Market-Reports/fertility-testing-devices-market-139945432.html
Early buyers will receive 10% customization on this report.
Early buyers will receive 10% customization on this report.
The emergence of advanced and easy-to-use
ovulation monitors with high accuracy, rising median age of first-time
pregnancies in women, and increasing awareness about fertility testing are
driving the growth of the market. In addition, factors such as declining
fertility rate among women across the globe and easy availability of ovulation
monitors on e-commerce websites are further stimulating the growth of the
market. However, the increasing inflow of generic fertility testing devices,
high cost of ovulation monitors, and lack of predictive power & precision
in modern ovulation prediction methods (to confirm ovulation) are restraining
the growth of the market.
Get
The PDF Brochure For This Report@
The global fertility testing devices
market is broadly categorized into two
segments, namely, ovulation
prediction kits and fertility
monitors. The ovulation prediction kits segment accounts for the larger
share of the global market, while the fertility monitors segment is expected to
grow at the higher CAGR in the forecast period. The high growth of this segment
is driven by the high accuracy of fertility monitors, especially in women
suffering from PCOS, and increase in the number of product launches of advanced
fertility monitors. The fertility monitors segment includes saliva-based
monitors, urine-based monitors, and others.
Based on the type of mode of purchase, the global fertility testing devices market is divided
into two segments prescription-based and non-prescription or OTC
(over-the-counter) based. The non-prescription or OTC-based segment commanded
the larger share of the global market. The large share of this segment is
attributed to the increasing initiatives taken by market players to spread
awareness on fertility, easy availability of fertility and ovulation monitors
on e-commerce websites, rising preference for confidentiality and accessibility
of test results, and rapid outcomes of diagnosis.
Download
Sample Pages of this Report@
Based on geography, the
market is divided into North America (comprising the U.S. and Canada), Europe
(comprising Germany, U.K., France, and the Rest of Europe), Asia-Pacific, and
the Rest of the World. In 2015, North America held the largest share in the
global fertility testing devices market, followed by Europe, Asia-Pacific, and
the RoW (Rest of the World). The Asia-Pacific region is estimated to grow at
the highest CAGR in the forecast period. Factors such as decreasing fertility
rate, growing number of women suffering from lifestyle disorders, rising
funding/investments for the development of fertility and ovulation monitors,
and growing focus of both international and domestic players on the
Asia-Pacific market are driving the growth of the fertility testing devices
market in the Asia-Pacific region.
The key players in the
fertility testing devices market include SPD Swiss Precision Diagnostics GmbH
(Switzerland), Church & Dwight Co., Inc. (U.S.), Prestige Brands Holdings,
Inc. (U.S.), Fairhaven Health, LLC (U.S.), HiLin Life Products, Inc. (U.S.),
Fertility Focus Limited (U.K.), and Geratherm Medical AG (Germany).
About MarketsandMarkets™:
MarketsandMarkets™
provides quantified B2B research on 30,000 high growth niche
opportunities/threats which will impact 70% to 80% of worldwide companies’
revenues. Currently servicing 5000 customers worldwide including 80% of global
Fortune 1000 companies as clients. Almost 75,000 top officers across eight
industries worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our 850 fulltime
analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets
following the "Growth Engagement Model – GEM". The GEM aims at
proactive collaboration with the clients to identify new opportunities,
identify most important customers, write "Attack, avoid and defend"
strategies, identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants
(Positioning top players across leaders, emerging companies, innovators,
strategic players) annually in high growth emerging segments.
MarketsandMarkets™ is determined to benefit more than 10,000 companies this year
for their revenue planning and help them take their innovations/disruptions
early to the market by providing them research ahead of the curve.
MarketsandMarkets’s
flagship competitive intelligence and market research platform, "RT"
connects over 200,000 markets and entire value chains for deeper understanding
of the unmet insights along with market sizing and forecasts of niche
markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
No comments:
Post a Comment